References
- De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23: 411–418
- Lengfelder E, Hochhaus A, Kronawitter U, Hoche D, Queisser W, Jahn-Eder M, Burkhardt R, Reiter A, Ansari H, Hehlmann R. Should a platelet limit of 600 × 109/L be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998; 100: 15–23
- Opitz T, Buchwald AB, Lorf T, Awuah D, Ramadori G, Nolte W. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis. Z Gastroenterol 2003; 41: 413–418
- Randi ML, Sartori MT, Luzzatto G, Ruzzon E, Boccagni P, Ragazzi R, Girolami A. Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis: Case report and literature review. Clin Appl Thromb Hemost 2002; 8: 369–374
- Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Pagliuca A, O'Grady J, Heaton N. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002; 73: 973–977
- Brancaccio V, Iannaccone L, Margaglione M, Guardascione MA, Amitrano L. Multiple thrombophilic factors in a patient with Budd-Chiari syndrome. Clin Lab Haematol 2002; 24: 61–63
- Marichy C, Dumontet C, Bastion Y, Rieux C, Blay JY, Salles G, Biron P, Coiffier B. Hepatic angiosarcoma in a patient with essential thrombocythaemia and Budd-Chiari syndrome. Eur J Cancer 1995; 31A: 423
- Lang H, Oldhafer KJ, Kupsch E, Ringe B, Pichlmayr R. Liver transplantation for Budd-Chiari syndrome–palliation or cure?. Transpl Int 1994; 7: 115–119
- Anger BR, Seifried E, Scheppach J, Heimpel H. Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases. Klin Wochenschr 1989; 67: 818–825
- Michiels JJ, Commandeur S, Hoogenboom GJ, Wegman JJ, Scholten L, van Rijssel RH, De Raeve H. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: Therapeutic implications in view of the literature. Ann Hematol. 2007; 86: 793–800
- Panagiotou I, Kelekis DA, Karatza C, Nikolaou V, Mouyia V, Brountzos EN. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt. Hepatogastroenterology 2007; 54: 1813–1816
- Hermeziu B, Franchi-Abella S, Plessier A, Habes D, Mosca A, Sibert A, Bernard O, Pariente D, Jacquemin E. Budd-Chiari syndrome and essential thrombocythemia in a child: Favorable outcome after transjugular intrahepatic portosystemic shunt. J Pediatr Gastroenterol Nutr 2008; 46: 334–337
- Musallam KM, Aoun E, Mahfouz R, Khalife M, Taher A. JAK2V617F and prothrombin g20210a gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia. Clin Appl Thromb Hemost 2009, [Epub ahead of print]
- Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, Pariente EA, Leporrier M, Rueff B, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985; 103: 329–334
- Besses C, Cervantes F, Pereira A, Florensa L, Sole F, Hernandez-Boluda JC, Woessner S, Sans-Sabrafen J, Rozman C, Montserrat E. Major vascular complications in essential thrombocythemia: A study of the predictive factors in a series of 148 patients. Leukemia 1999; 13: 150–154
- Lahuerta-Palacios JJ, Bornstein R, Fernandez-Debora FJ, Gutierrez-Rivas E, Ortiz MC, Larregla S, Calandre L, Montero-Castillo J. Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia. Cancer 1988; 61: 1207–1212
- Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29–39
- Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol 2002; 29(3 Suppl)16–21